Skip to main content
. 2019 Jun 27;7:261. doi: 10.3389/fped.2019.00261

Table 1.

Baseline demographic and clinical characteristics of the study participants.

Characteristics Values
Participants (n) 115
Age (years) 12.0 (10.0, 13.0)
Gender (n, male/female) 50/65
Body mass index (kg/m2) 17.4 (16.1, 19.8)
Duration of symptoms before treatment (months) 10.5 (2.0, 36.0)
MEDICAL HISTORY
Predisposing factors (n, yes/no) 77/38
Syncope (n, yes/no) 61/54
Symptom scores before treatment (points) 4 (3, 7)
PERSONAL HISTORY
Motion sickness (n, yes/no) 16/99
Allergic diseases (n, yes/no) 29/86
Family history about OI (n, yes/no) 29/86
CHARACTERISTICS IN STANDING-UP TEST
Supine heart rate (bpm) 74 ± 11
Maximum upright heart rate (bpm) 121 ± 14
Changes of heart rate (bpm) 46 (40, 53)
ITEMS OF BLOOD ROUTINE TEST
Mean corpuscular hemoglobin concentration (g/L) 347 (339, 354)
Platelet (*109/L) 257 (229, 298)
24 h urinary sodium excretion (mmol/24 h) 102 (73, 135)
Duration of treatment (months) 3.5 (3, 5)

OI, orthostatic intolerance. Continuous data with normal distribution are presented as mean ± standard deviation, otherwise as median (P25, P75) and categorical variables are summarized as numbers.